Cooperate in earlier settlement of differential pricing in insurance-covered drugs

Published: 2003-02-06 06:57:00

Updated: 2003-02-06 06:57:00

In response to the request from the Korea Pharmaceutical Association (KPA), the Korea Pharmaceutical Manufacturers Association (KPMA) has recently dispatched an official letter to its members, to this effect:

- Rapid compensation of differential reimbursement pricing associated with frequent r...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK